1 |
Grundmann H, M Aires-de-Sousa, J Boyce and E Tiemersama. 2006. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368:874-885.
DOI
|
2 |
Gulder TA and BS Moore. 2009. Chasing the treasures of the sea-bacterial marine natural products. Curr. Opin. Microbiol. 12:252-260.
DOI
|
3 |
Hamann MT and PJ Scheuer. 1993. Kahalalide F: a bioactive depsipeptide from the sacoglossan mollusk Elysia rufescens and the green alga Bryopsis sp. J. Am. Chem. Soc. 115: 5825-1826.
DOI
|
4 |
Hong SN, J Kim and HH Sung. 2016. A study on changes in antimicrobial resistant Staphylococcus aureus from wound isolates in a South Korean University hospital for the past 10 years. Korean J. Clin. Lab. Sci. 48:335-342.
DOI
|
5 |
Howden BP, JK Davies, PD Jonhson, TP Stinear and ML Grayson. 2010. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin. Microbiol. Rev. 23:99-139.
DOI
|
6 |
Hiramatsu K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1:147-155.
DOI
|
7 |
Jung JH and HC Chang. 2009. Bacillus polufermenticus CJ9, isolated from Jeju, showing antifugal and antibacterial activities. Korean J. Microbiol. Biotechnol. 37:340-349.
|
8 |
Kim ES, SI Jeong, JH Kim, C Park, SM Kim, JK Kim, KM Lee, SH Lee, H So and R Park. 2009. Synergistic effects of the combination of 20-hydroxyecdysone with ampicillin and gentamicin against methicillin-resistant Staphylococcus aureus. J. Microbiol. Biotechnol. 19:1576-1581.
DOI
|
9 |
Kitai S, A Shimizu, J Kawano, E Sato, C Nakano, T Uji and H Kitagawa. 2005. Characterization of methicillin-resistant Staphylococcus aureus isolated from retail raw chicken meat in Japan. J. Vet. Med. Sci. 67:107-110.
DOI
|
10 |
Shiota S, M Shimizu, J Sugiyam, Y Morita, T Mizushima and T Tsuchiya. 2004. Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 48:67-73.
DOI
|
11 |
Taga N. 1968. Some ecological aspects of marine bacteria in the KuroShio current. Bull. Misaki Mar. Biol. Inst. Kyoto Univ. 12:65-76.
|
12 |
Tamura K, D Peterson, N Peterson, G Stecher, M Nei and S Kumar. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28: 2731-2739.
DOI
|
13 |
Watve MG, R Tickoo, MM Jog and BD Bhole. 2001. How many antibiotics are produced by the genus Streptomyces? Arch. Microbiol. 176:386-390.
DOI
|
14 |
Yee C, D Biek, K Karause and G Williams. 2011. Ceftarolin: a cephalosporin with anti-MRSA activity. Clin. Microbiol. Newsl. 33:161-169.
DOI
|
15 |
Yucel N, S Citak and M Onder. 2005. Prevalence and antibiotic resistance of Listeria species in meat products in Ankara, Turkey. Food Microbiol. 22:241-245.
DOI
|
16 |
Cha JD, JH Lee, KM Choi, SM Choi and JH Park. 2014. Synergistic effect between cryptotanshinone and antibiotics against clinic methicillin and vancomycin-resistant Staphylococcus aureus. Evid.-based Complement Altern. 2014:450572.
|
17 |
Bell JM, JD Tumidge and A Sentry. 2002. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia Pacific and South Africa: results from sentry antimicrobial surveillance program, 1998-1999. Antimicrob. Agents Chemother. 46:879-881.
DOI
|
18 |
Berdy JJ. 2005. Bioactive microbial metabolites. J. Antibiot. 58:1-26.
DOI
|
19 |
Boyle-Vavra S, RB Carey and RS Daum. 2001. Development of vancomycin and lysostaphin resistance in a methicillinresistant Staphylococcus aureus isolate. J. Antimicrob. Chemother. 48:617-625.
DOI
|
20 |
Crum NF, RU Lee, SA Thornton, OC Stine, MR Wallace, C Barrozo, A Keffer-Norris, S Judd and KL Russell. 2006. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am. J. Med. 119:943-951.
DOI
|
21 |
Fritza E, A Fekete, J Lintelmann, P Schmitt-Kopplin and RU Meckenstock. 2009. Isolation of two Pseudomonas strains producing pseudomonic acid A. Syst. Appl. Microbiol. 32: 56-64.
DOI
|
22 |
Davis SL, MB Perri, SM Donabedian, C Manierski, A Robinson-Dunn, MK Hayden and MJ Zervos. 2007. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J. Clin. Microbiol. 45:1705-1711.
DOI
|
23 |
Dunbar J, LO Tickno and CR Kuske. 2000. Assessment of microbial diversity in four Southwestern United States soils by 16S rRNA gene terminal restriction fragment analysis. Appl. Environ. Microbiol. 66:2943-2950.
DOI
|
24 |
Faver B, B Hofbauer, KS Hildering and NS Ryder. 2003. Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay. J. Clin. Microbiol. 41:4817-4819.
DOI
|
25 |
Nagai K, K Kanigiri, N Arao, K Suzumura, Y Kawano, M Yamaoka, H Zhang, H Zhang, M Watanabe and K Suzuki. 2003. Novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge. I. Taxonomy, fermentation, isolation, physicochemical properties and biological properties. J. Antibiot. 56:123-128.
DOI
|
26 |
Koehn FE and GT Carter. 2005. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 4:206-220.
DOI
|
27 |
Lee K, SJ Jang, HJ Lee, N Ryoo, M Kim, SG Hong and Y Chong. 2004. Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pnuemoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: Konsar study in 2001. J. Korean Med. Sci. 19:8-14.
DOI
|
28 |
MacFaddin JF. 1980. Biochemical tests for identification of medical bacteria. 2nd ed. Williams and Wilkins Co., Baltimore.
|
29 |
Bassetti M, E Nicco and M Mikulska. 2009. Why is community-associated MRSA spreading across the world and how will it change clinical practice? Int. J. Antimicrob. Agents 34:S15-S19.
|
30 |
Akcam FZ, GB Tinaz, O Kaya, A Tigl, E Ture and S Hosoglu. 2009. Evaluation of methicillin resistance by cefoxitin disk diffusion and PBP2a latex agglutination test in mecApositive Staphylococcus aureus, and comparison of mecA with femA, femB, femX positivities. Microbiol. Res. 164: 400-403.
DOI
|
31 |
Salomon CE, NA Magarvey and DH Sherman. 2004. Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery. Nat. Prod. Rep. 21:105-121.
DOI
|
32 |
National Committee for Clinical Laboratory Standards. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M07-A8. 8th ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
|
33 |
Park YJ, JS Jeong, ES Park, ES Shin, SH Kim and YS Lee. 2007. Survey on the infection control of multidrug-resistant microorganisms in general hospitals in Korea. Korean J. Nosocomial Infect. Control 12:112-121.
|
34 |
Proksch P, RA Edrada and R Ebel. 2003. Drugs from the seaopportunities and obstacles. Mar. Drugs 1:5-17.
DOI
|
35 |
Sambrook J, EF Fritsch and T Maniatis. 1989. Molecular cloning, a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory, New York.
|